Lenalidomide for Second-line Treatment of Advanced Hepatocellular Cancer

Title
Lenalidomide for Second-line Treatment of Advanced Hepatocellular Cancer
Authors
Keywords
-
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-05-03
DOI
10.1097/coc.0b013e3182868c66

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started